Buy The current consensus among 19 investment analysts is to buy stock in BioMarin Pharmaceutical. Stock analysis for BioMarin Pharmaceutical Inc (BMRN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Investors can use this forecasting interface to forecast BioMarin Pharmaceutical historical stock pricesstock prices 2021 is $87.44 , for Feb. 2022 is $77.03 , for Feb. 2024 is $49.05 , for Feb. 2026 is $34.19 , and for Feb. 2031 is $191.78. Since then, BMRN stock has risen by 540.27%, with an average of 25.73% per year. TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Intel and BioMarin. 4 brokerages have issued 12-month target prices for Pacific Biosciences of California's stock. View BioMarin Pharmaceutical Inc. BMRN investment & stock information. Biomarin Pharmaceutical Inc (BMRN:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Is BioMarin Pharmaceutical (NASDAQ:BMRN) the best stock in its category? How is BioMarin Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 21 analysts? MRNS | Complete Marinus Pharmaceuticals Inc. stock news by MarketWatch. BioMarin Pharmaceutical (NASDAQ:BMRN) had its price objective trimmed by Canaccord Genuity from $95.00 to $91.00 in a research report released on Monday morning, Price Targets.com reports. The average price target is $117.36, with a high forecast of $218.00 and a low forecast of $77.00. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The consensus forecast at Sentieo.com sees BioMarin breaking even in 2021, then earning about $1.35 in 2022, $3.00 in 2023, and $5.00 in 2024. However, solely looking at the historical price movement is usually misleading. The shares are currently trading at $77.43. Buy. BMRN | Complete BioMarin Pharmaceutical Inc. stock news by MarketWatch. BMRN stock RSI chart BioMarin Pharmaceutical stock price history. $125.00 +63.72%. See BioMarin Pharmaceutical Inc. (BMRN) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Is BioMarin Pharmaceutical (NASDAQ:BMRN) the best stock in its category? $103.75 +35.89%. View BMRN's key competitors at MarketBeat. According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. Real time BioMarin Pharmaceutical (BMRN) stock price quote, stock graph, news & analysis. In the short term (2weeks), BMRN's stock price should outperform the market by 0.73%.During that period the price should oscillate between -4.30% and +4.94%.. BioMarin Pharmaceutical Stock Forecast is based on your current time horizon. The company has signed a drug development deal with Swiss biotech company Serono. View the latest BioMarin Pharmaceutical Inc. (BMRN) stock price, news, historical charts, analyst ratings and financial information from WSJ. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) – Equities research analysts at Wedbush cut their FY2021 earnings estimates for BioMarin Pharmaceutical in a research report issued to clients and investors on Monday, March 1st. The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Biomarin Pharmaceutical Inc. To summarize, we found that Biomarin Pharmaceutical Inc ranked in the 0th percentile in terms of potential gain offered. BioMarin Pharmaceutical Inc. Stock Forecast NASDAQ:BMRN Price Target and Analyst Ratings. Last 30 Days. BMRN stock forecast Our latest prediction for Biomarin Pharmaceutical Inc.'s stock price was made on the April 8, 2019 when the stock price was at 92.38$.. Johnson & Johnson is … Our DCF analysis suggests the stock is overvalued by about 100%. This suggests a possible upside of 51.4% from the stock's current price. Overview Forecast. BioMarin Pharmaceutical Inc., which has a market valuation of $16.28 Billion as of writing, is expected to release its quarterly earnings report on Feb 24, 2021- Mar 01, 2021. Avg Forecast. View BMRN's key competitors at MarketBeat. S&P 500 3,841.94 (+1.95%) DOW 31,496.30 (+1.85%) QQQ 308.68 (+1.51%) AAPL 121.42 (+1.07%) MSFT 231.60 (+2.15%) FB 264.28 (+2.58%) GOOGL 2,097.07 … BioMarin Pharmaceutical Stock Forecast is based on your current time horizon. Their forecasts range from $15.00 to $62.00. BioMarin Pharmaceutical started trading on Jul 26th, 1999 priced at $13.31 per share 1. Most Recent Rating. If you had invested $1,000USD in BioMarin Pharmaceutical stock on Jul 1999, it would worth $6,402.70 today. On average, they anticipate Pacific Biosciences of California's share price to reach $43.50 in the next twelve months. From AI system, total return is 1638.42% from 1197 forecasts. Will BioMarin Pharmaceutical Inc stock go up? Max Forecast. Is BioMarin Pharmaceutical Inc stock a good buy now? This Buy consensus rating has held steady for over two years. Find the latest analyst research for BioMarin Pharmaceutical Inc. Common Stock (BMRN) at Nasdaq.com. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Analyst price target for BMRNBased on 8 analysts offering 12 month price targets for Biomarin Pharmaceutical Inc. Min Forecast. The Biomarin Pharmaceutical Inc share price has risen by 14.1% over the past month and it’s currently trading at 91.79.For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue. The stock added 16.33% on its value in the past month. $86.00 +12.64%. Past Monthly Recommendations. Investors can use this forecasting interface to forecast BioMarin Pharmaceutical historical stock prices and determine the direction of BioMarin Pharmaceutical's future trends based on various well-known forecasting models.